Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Filgrastim × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Myelodysplastic Syndromes 7 Leukemia, Biphenotypic, Acute 6 Hodgkin Disease 6 Burkitt Lymphoma 5 Breast Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Hematologic Neoplasms 4 Neuroblastoma 3 Neoplasms 3 Medulloblastoma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Myelomonocytic, Chronic 2 Leukemia 2 Bronchiolitis Obliterans Syndrome 2 Anemia, Refractory, with Excess of Blasts 2 Triple Negative Breast Neoplasms 1 Teratoma 1 Sleep Initiation and Maintenance Disorders 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Pinealoma 1

Interventions

Dexamethasone 116 Lenalidomide 72 daratumumab 65 Bortezomib 52 carfilzomib 44 pomalidomide 41 Cyclophosphamide 38 Calcium Dobesilate 38 Specimen Handling 32 Biopsy 29 fludarabine 25 Magnetic Resonance Spectroscopy 24 talquetamab 19 isatuximab 17 iberdomide 16 fludarabine phosphate 14 dexamethasone acetate 14 dexamethasone 21-phosphate 14 auricularum 14 selinexor 11 elotuzumab 10 belantamab mafodotin 10 Melphalan 10 tocilizumab 9 X-Rays 9 trametinib 7 Nivolumab 7 Whole-Body Irradiation 6 venetoclax 5 idecabtagene vicleucel 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03909412 2026-02-18

CarMob

Hackensack Meridian Health

Phase 1 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡